Skip to Content

93 784 (Tamoxifen 10 mg)

Pill imprint 93 784 has been identified as Tamoxifen citrate 10 mg.

Tamoxifen is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, male; precocious puberty; breast cancer, adjuvant (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 10 mg is not a controlled substance under the Controlled Substance Act (CSA).

Tamoxifen citrate 10 mg 93 784
Tamoxifen citrate 10 mg 93 784  Front
Tamoxifen citrate 10 mg 93 784  Back
Tamoxifen citrate 10 mg 93 784
Tamoxifen citrate
Imprint:
93 784
Strength:
10 mg
Color:
White
Size:
5.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Hormones/antineoplastics
Selective estrogen receptor modulators
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-0784
Inactive Ingredients:
croscarmellose sodium
hypromellose 2910 (5 mPa.s)
lactose monohydrate
magnesium stearate
polyethylene glycol 400
povidone k30
corn starch
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
63739-0269 McKesson Packaging Services
54569-3765 A-S Medication Solutions, LLC (repackager)
54868-3004 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide